Visium Asset Management’s NEPHROGENEX INC COM NRX Stock Holding History

Visium Asset Management’s Portfolio NRX Stock Details NRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-790,000	Closed	-$371K	–	589
2016 Q1	$371K	Hold	790,000	–	–	0.01%	460
2015 Q4	$1.26M	Hold	790,000	–	–	0.02%	442
2015 Q3	$2.67M	Buy	790,000 +130,000	+20%	+$570K	0.04%	398
2015 Q2	$4.38M	Hold	660,000	–	–	0.06%	308
2015 Q1	$5.19M	Buy	660,000 +1,031	+0.2%	+$8.09K	0.08%	255
2014 Q4	$8.8M	Buy	658,969 +181,969	+38%	+$843K	0.12%	150
2014 Q3	$2.23M	Buy	477,000 +509	+0.1%	+$2.42K	0.03%	449
2014 Q2	$2.87M	Hold	476,491	–	–	0.04%	329
2014 Q1	$3.93M	Buy	+476,491	New	+$4.86M	0.06%	273

Visium Asset Management's NRX Position: Q2 2016 in Review

Visium Asset Management sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 790,000 shares — an estimated $371K sold.

Visium Asset Management first reported a position in NRX in Q1 2014 and held it in 9 quarters. The position peaked at $8.8M in Q4 2014. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

Visium Asset Management reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 790,000 NEPHROGENEX INC COM shares in Q2 2016, an estimated $371K.
Visium Asset Management first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 9 quarters.
Visium Asset Management's NEPHROGENEX INC COM position peaked at $8.8M in Q4 2014.
1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.